BioSensics retweeted
Preop gait variability is a prognostic predictor of gait and balance in Parkinson disease patients with deep brain stimulation
Log in :
prd-journal.com/article/S135…
Given the overall evidence for amyloid-centric #Alzheimers treatments, do you think #Lecanemab will prove effective? @biogen @EisaiUS
Here we go again. By the end of September, we will learn whether lecanemab, another Biogen and Eisai Alzheimer's treatment aimed at amyloid, can significantly slow cognitive decline. statnews.com/2022/08/10/ever… via @statnews
Soda, breakfast cereal and frozen (processed) foods associated with long-term cognitive decline #alzheimers #dementia #AAIC22
news-leader.com/story/news/l…
Iron Buildup in Brain Linked to Higher Risk for Movement Disorders.
Hemochromatosis gene mutation carriers have increased risk of developing #movementdisorders including #Parkinsons.
neurosciencenews.com/iron-ge…
BioSensics retweeted
#BREAKINGNEWS: Our Sensor Cloud has secured "Best Biometric Sensor Solution" in the 6th annual @MedTech_Awards program, which honors #Innovation in #DigitalHealth and #MedTech. This year's program attracted 3900+ nominations from 15+ countries. Read more: mdso.io/g4o
#AlzheimersDisease is the most common neurodegenerative disorder (7M cases globally), followed by #Parkinsonsdisease
BioSensics retweeted
I had a great time meeting the fine folks at @OrphanConf @BioSensics
Thank you @OrphanConf for hosting a meaningful conference impacting patients of rare desease. looking forward to next time!
I had a great time meeting the fine folks at @OrphanConf @BioSensics
What is a #digitalbiomarker?
Objective, quantifiable, physiological, and behavioral measures collected by means of digital devices that are portable, wearable, implantable, or digestible.
biosensics.com/technologies
LEGSys was used in a new clinical study measuring motor performance in #Parkinson's patients. The study aimed to assess the feasibility of wearable devices in early detection of PD motor-cognitive decline: karger.com/Article/Abstract/…
Learn more about LEGSys: biosensics.com/technologies/…
Traditional #ALS assessments are largely subjective, and require in-clinic visits.
ALS study participant (Male, 72 years old, ALSFRS at baseline = 34) performs Spiral Tracing Assessment on BioDigit Home (link below for more)
biosensics.com/products/biod…
cc @ALSTDI @ALSAMA @ALSAMA
People with higher levels of antioxidants in their blood may be less likely to develop #dementia, according to a study published in Neurology
neurosciencenews.com/dementi…
BioSensics retweeted
Have you changed your slides to reflect the new image of Parkinson's disease by Armstrong et. al. in JAMA Neurology? Time to retire the Gower's sketch.
ow.ly/Cyzm50BDOmC










